Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AMXI-5001 by AtlasMedx for Ovarian Cancer: Likelihood of Approval
AMXI-5001 is under clinical development by AtlasMedx and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
Data Insights
AMXI-5001 by AtlasMedx for Advanced Malignancy: Likelihood of Approval
AMXI-5001 is under clinical development by AtlasMedx and currently in Phase II for Advanced Malignancy. According to GlobalData, Phase II...